CAPR

8.36

2.45% -0.21

Handel nachbörslich: 8.39 0.03 +0.36%

Capricor Therapeutics Inc (CAPR)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt CAPR? Forum Prognose Aktiensplit

Schlusskurs vom Vortag:

$8.57

Offen:

$8.61

24-Stunden-Volumen:

1.90M

Relative Volume:

0.31

Marktkapitalisierung:

$486.04M

Einnahmen:

$11.13M

Nettoeinkommen (Verlust:

$-114.59M

KGV:

-3.6144

EPS:

-2.313

Netto-Cashflow:

$-113.96M

1W Leistung:

-7.73%

1M Leistung:

+0.84%

6M Leistung:

-72.04%

1J Leistung:

+28.22%

1-Tages-Spanne:

$8.30

$8.67

1-Wochen-Bereich:

$8.27

$9.48

52-Wochen-Spanne:

$2.96

$40.37

Capricor Therapeutics Inc Stock (CAPR) Company Profile

Firmenname

Capricor Therapeutics Inc

Sektor

Healthcare (1067)

Branche

Biotechnology (595)

Telefon

(310) 358-3200

Adresse

10865 ROAD TO THE CURE, SAN DIEGO, CA

Mitarbeiter

231

Twitter

@Capricor

Nächster Verdiensttermin

2026-11-09

Neueste SEC-Einreichungen

CAPR's Discussions on Twitter

Compare CAPR vs VRTX, REGN, MRNA, ARGX, RVMD

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
CAPR Capricor Therapeutics Inc	8.36	486.04M	11.13M	-114.59M	-113.96M	-2.313
VRTX Vertex Pharmaceuticals Inc	526.19	133.37B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	788.04	81.13B	14.92B	4.42B	3.79B	41.04
MRNA Moderna Inc	198.88	79.40B	2.23B	-3.19B	-1.60B	-8.1462
ARGX Argen X Se Adr	959.49	60.03B	4.16B	1.29B	734.26M	19.58
RVMD Revolution Medicines Inc	204.97	43.93B	742.00K	-1.37B	-1.07B	-7.0731

Capricor Therapeutics Inc Stock (CAPR) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-06-30	Eingeleitet	Alliance Global Partners	Buy
2025-06-26	Eingeleitet	B. Riley Securities	Buy
2025-05-20	Eingeleitet	Roth Capital	Buy
2024-10-21	Eingeleitet	Piper Sandler	Overweight
2024-05-17	Eingeleitet	Oppenheimer	Outperform
2024-01-05	Eingeleitet	Cantor Fitzgerald	Overweight
2022-10-26	Eingeleitet	Ladenburg Thalmann	Buy
2018-12-26	Herabstufung	Maxim Group	Buy → Hold
2018-01-26	Bestätigt	H.C. Wainwright	Buy
2017-09-15	Bestätigt	H.C. Wainwright	Buy
2017-02-13	Fortgesetzt	Rodman & Renshaw	Buy
2016-07-06	Fortgesetzt	H.C. Wainwright	Buy
2016-06-15	Eingeleitet	ROTH Capital	Buy

Alle ansehen

Capricor Therapeutics Inc Aktie (CAPR) Neueste Nachrichten

01:26 AM

CAPR 2-DAY DEADLINE ALERT: Capricor Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Shareholder Class Action Lawsuit Before September 28, 2026 Deadline - GlobeNewswire Inc.

01:26 AM

07:28 AM

(CAPR) and the Role of Price-Sensitive Allocations - Stock Traders Daily

07:28 AM

Sep 25, 2026

Kaplan Fox Urges Capricor Therapeutics, Inc. (NASDAQ: CAPR) Investors to Contact the Firm Before the Deadline on September 28, 2026 - The Globe and Mail

Sep 25, 2026

Securities Fraud Class Action Filed Against Capricor Therapeutics, Inc. (CAPR)Levi & Korsinsky Reminds Investors of September 28, 2026 - accessnewswire.com

Sep 25, 2026

Levi & Korsinsky Notifies Capricor Therapeutics, Inc. (CAPR) InvestorsLead Plaintiff Deadline on September 28, 2026 - accessnewswire.com

Sep 25, 2026

Class Action Lawsuit Alert: Levi & Korsinsky Reminds Capricor Therapeutics, Inc. (CAPR) Investors of September 28, 2026 Deadline - ACCESS Newswire

Sep 25, 2026

CAPR INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Capricor Therapeutics, Inc. Shareholders Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire

Sep 25, 2026

CAPRICOR DEADLINE SEPTEMBER 28th: Bragar Eagel & Squire, - GlobeNewswire

Sep 25, 2026

CAPR Stock On Track For Worst Week Ever After Regulatory Setback For DMD Therapy - Stocktwits

Sep 25, 2026

Did You Lose Money on Capricor Therapeutics, Inc. (CAPR)? Levi & Korsinsky Urges Investors to Act Before September 28, 2026 - ACCESS Newswire

Sep 25, 2026

Shareholders of Capricor Therapeutics, Inc. (CAPR): Protect Your Rights Before September 28, 2026Contact Levi & Korsinsky - ACCESS Newswire

Sep 25, 2026

Sep 24, 2026

Kaplan Fox Announces a Securities Class Action Filed Against Capricor Therapeutics, Inc. (NASDAQ: CAPR)Lead Plaintiff Deadline is September 28, 2026 - The Globe and Mail

Sep 24, 2026

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Capricor Therapeutics, Inc. of Class Action Lawsuit and Upcoming DeadlinesCAPR - PR Newswire

Sep 24, 2026

September 28, 2026 Deadline Approaching: Join Class Action Against Capricor Therapeutics, Inc. (CAPR)Contact Levi & Korsinsky - accessnewswire.com

Sep 24, 2026

CAPR STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Capricor Therapeutics, Inc. Investors with Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire

Sep 24, 2026

CAPR STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Anno - natlawreview.com

Sep 24, 2026

CAPR Deadline: CAPR Investors with Losses in Excess of $100K Have Opportunity to Lead Capricor Therapeutics, Inc. Securities Fraud Lawsuit - Morningstar

Sep 24, 2026

Capricor Therapeutics Shareholder Alert: ClaimsFiler - GlobeNewswire

Sep 24, 2026

Kaplan Fox Continues to Remind Capricor Therapeutics, Inc. (NASDAQ: CAPR) Investors of the Lead Plaintiff Deadline on September 28, 2026 - The Globe and Mail

Sep 24, 2026

SueWallSt Reminds Capricor Therapeutics Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of September 28, 2026CAPR - PR Newswire

Sep 24, 2026

CAPR Investors Have Opportunity to Lead Capricor Therapeutics, Inc. Securities Fraud Lawsuit with SBS Law - GlobeNewswire

Sep 24, 2026

SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A - GlobeNewswire

Sep 24, 2026

Sep 23, 2026